The fountain of youth may be hiding in the graveyard. “By day three, I was looking like a newborn baby dumpling,” said one ...
SEONGNAM, South Korea, Dec. 2, 2025 /PRNewswire/ -- L&C Bio (KOSDAQ: 290650, Co-CEOs Hwan-Chul Lee and Jae-Ho Lee), a leading company in human tissue–based regenerative medicine, announced that its ...
L&C BIO, a regenerative medicine company specializing in human tissue, said on the 11th that it posted 30.3 billion won in sales and 6 billion won in operating profit on a consolidation basis in the ...
8don MSN
Cadaver collagen injectables are made from donated human skin—and they're booming in South Korea
The science, the ethics, and whether it's coming to the UK.
L&C BIO is expected to surpass 100 billion won in annual revenue this year for the first time. As interest in K-beauty rises, demand for the skin booster Re2O is increasing, and the company is ...
Humedics introduced 'Elravie Re2O,' presenting a new paradigm for ECM (extracellular matrix) fillers. On the 28th, Humedics announced that it has been continuously conducting academic marketing ...
This growth is particularly remarkable considering that Re2O had relatively low brand recognition only six months ago. Dermatology and plastic surgery clinics, as well as major university hospitals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results